Beta Bionics, Inc. (BBNX) FCF Margin (2024 - 2026)

Beta Bionics (BBNX) has 3 years of FCF Margin data on file, last reported at 91.25% in Q1 2026.

• Quarterly FCF Margin rose 2388.0% year-over-year to 91.25% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 55.45% (up 2965.0% YoY) and the FY2025 annual result came in at 56.08%, up 2326.0% from the prior year.
• FCF Margin eased to 91.25% in Q1 2026 per BBNX's latest filing, from 43.23% in the prior quarter.
• The five-year high for FCF Margin was 31.8% in Q3 2025, with the low at 115.13% in Q1 2025.
• Average FCF Margin over 3 years is 73.59%, with a median of 72.6% recorded in 2024.
• The widest YoY moves for FCF Margin: up 3699 bps in 2025, down 1809 bps in 2025.
• Beta Bionics' FCF Margin stood at 72.6% in 2024, then soared by 40 bps to 43.23% in 2025, then tumbled by 111 bps to 91.25% in 2026.
• Business Quant data shows BBNX's FCF Margin at 91.25% in Q1 2026, 43.23% in Q4 2025, and 31.8% in Q3 2025.